Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ASPARAGINASE for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where ASPARAGINASE was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for ASPARAGINASE

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 557 11.2% 96 270
Neutropenia 322 6.5% 50 130
Bacterial infection 295 5.9% 255 10
Off label use 267 5.4% 118 88
Secondary immunodeficiency 233 4.7% 212 3
Viral infection 228 4.6% 228 3
Clostridium difficile colitis 213 4.3% 201 16
Pyrexia 204 4.1% 39 123
Sepsis 200 4.0% 95 70
Pneumonia 196 3.9% 143 41
Posterior reversible encephalopathy syndrome 195 3.9% 4 63
Bronchopulmonary aspergillosis 194 3.9% 163 11
Drug ineffective 192 3.9% 72 59
Mycobacterium chelonae infection 170 3.4% 170 1
Death 169 3.4% 169 10

Other Indications for ASPARAGINASE

Acute lymphocytic leukaemia (2,690) T-cell type acute leukaemia (282) Product used for unknown indication (278) B precursor type acute leukaemia (214) B-cell type acute leukaemia (207) Angiocentric lymphoma (148) Non-hodgkin's lymphoma (135) Precursor t-lymphoblastic lymphoma/leukaemia (118) Chemotherapy (98) Acute myeloid leukaemia (68)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

ASPARAGINASE Full Profile All Diffuse large b-cell lymphoma Drugs ASPARAGINASE Demographics ASPARAGINASE Timeline